½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

  • »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

    021-54845833/15800441009

    Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

    µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > ÆäËû¿¹Ìå > BCCIP¿¹Ô­£¨ÖØ×éµ°°×£©

    ²úÆ·ÖÐÐÄ

    ×îвúÆ·

    • BCCIP¿¹Ô­£¨ÖØ×éµ°°×£©

      ¹æ¸ñ£º
      ¼Û¸ñ£º£¤
      • Æ·ÅÆ : ͨεÉúÎï
      • Ŀ¼ºÅ : TW16810
      • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
      • »õÆÚ : ÏÖ»õ
      • ¹æ¸ñ £º1mg/100ug
    • ÉÌÆ·ÏêÇé
    • ²Î¿¼ÎÄÏ×
    • ˵Ã÷ÊéÏÂÔØ
    • ÉÌÆ·ÆÀÂÛ0
    • Ïà¹Ø²úÆ·

    ÖÐÎÄÃû³Æ£ºBCCIP¿¹Ô­£¨ÖØ×éµ°°×£©

    Ó¢ÎÄÃû³Æ£º BCCIP Antigen (Recombinant Protein)

    ±ð      Ãû£º TOK1; TOK-1

    ´¢      ´æ£º Àä¶³£¨-20¡æ£©

    Ïà¹ØÀà±ð£º ¿¹Ô­

    ¸Å  Êö£º

    Fusion protein corresponding to a region derived from 59-167 amino acids of human BCCIP


    ¼¼Êõ¹æ¸ñ£º

    Full name:

    BRCA2 and CDKN1A interacting protein

    Synonyms:

    TOK1; TOK-1

    Swissprot:

    Q9P287

    Gene Accession:

    BC009771

    Purity:

    >85%, as determined by Coomassie blue stained SDS-PAGE

    Expression system:

    Escherichia coli

    Tags:

    His tag C-Terminus, GST tag N-Terminus

    Background:

    This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene.


    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿